Skip to main content
. 2021 Jul 16;12:680298. doi: 10.3389/fpsyt.2021.680298

Table 2.

Sex, comorbid psychological diagnoses, and treatment objectives for pediatric ARFID patients (n = 26) admitted to a specialized pilot clinic.

Aversive Hx (n = 6) Sensory(n = 2) Low appetite, limited interest (n = 8) ARFID-Mixed(n = 10) ARFID total (n = 26)
No. (%) No. (%) No. (%) No. (%) No. (%)
Female 5 (83.33%) 2 (100%) 5 (62.50%) 4 (40%) 16 (62.50%)
Comorbidities
Mood 3 (50.0%) 1 (50%) 2 (25%) 3 (30%) 9 (34.60%)
Anxiety 6 (100.0%) 2 (100%) 4 (50%) 7 (70%) 19 (73.1%)
Autism 1 (16.67%) 1 (50%) 0 (0%) 4 (40%) 6 (23.1%)
OCD 2 (33.33%) 0 (0%) 0 (0%) 2 (20%) 4 (15.4%)
ADHD 2 (33.33%) 1 (50%) 0 (0%) 3 (30%) 6 (23.1%)
Learning difficulties (has IEP) 1 (16.7%) 0 (0%) 3 (37.50%) 4 (40%) 8 (30.8%)
Treatment Objectives
Weight gain 6 (100%) 2 (100%) 8 (100%) 9 (90%) 25 (96.2%)
Increasing food variety 0 (0%) 2 (100%) 0 (0%) 6 (60%) 8 (30.8%)

OCD, obsessive compulsive disorder; ADHD, attention deficit hyperactivity disorder; IEP, individualized education program.